MYMX fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Mymetics Corp. is a vaccine company, which focuses on the research and development of next generation vaccines for infectious and life disabling diseases. Its vaccine pipeline includes Influenza and RSV, HIV/AIDS, Malaria, Immunotheraphy, and COVID-19. The company was founded in July 1994 and is headquartered in Epalinges, Switzerland.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
MYMX has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company